19.07

1.87% 0.35

After Hours: 19.24 0.17 +0.89%

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $19.07, with a volume of 136.72K. It is up +1.87% in the last 24 hours and up +84.25% over the past month. Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Previous Close:

$18.72

Open:

$18.51

24h Volume:

136.72K

Relative Volume:

0.10

Market Cap:

$188.00M

Revenue:

$49.09M

Net Income/Loss:

$-52.15M

P/E Ratio:

-29.34

EPS:

-0.65

Net Cash Flow:

$-45.93M

1W Performance:

+24.64%

1M Performance:

+84.25%

6M Performance:

+130.87%

1Y Performance:

+16.84%

1-Day Range:

$18.21

$19.25

1-Week Range:

$14.55

$19.71

52-Week Range:

$3.436

$19.71

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1109)

Industry

Diagnostics & Research (53)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

334

Twitter

Next Earnings Date

2025-10-31

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	19.07	184.55M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	495.72	185.77B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	195.06	138.05B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	600.52	47.68B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	115.42	32.62B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	297.54	29.39B	3.17B	642.63M	516.49M	10.77

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-27-26	Upgrade	William Blair	Mkt Perform → Outperform
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

Mar 11, 2026

Biodesix at Barclays Conference: Strategic Growth in Lung Cancer Diagnostics - Investing.com Canada

Mar 11, 2026

Mar 09, 2026

Biodesix Earnings Call Signals Growth With Caveats - TipRanks

Mar 09, 2026

Mar 08, 2026

Setup Watch: Is Biodesix Inc in a consolidation phase2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn

Mar 08, 2026

Mar 07, 2026

Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Mar 07, 2026

Mar 06, 2026

Guidance Update: What is the dividend yield of Biodesix IncRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 06, 2026

Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference - MarketBeat

Mar 06, 2026

Mar 05, 2026

What analysts say about Biodesix Inc stock2025 Dividend Review & Daily Stock Momentum Reports - baoquankhu1.vn

Mar 05, 2026

How The Biodesix (BDSX) Investment Story Is Shifting After Guidance And New US$30 Target - Yahoo Finance

Mar 05, 2026

Mar 03, 2026

Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget

Mar 03, 2026

Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz

Mar 03, 2026

Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget

Mar 02, 2026

Canaccord reiterates Biodesix stock rating on strong Q4 results By Investing.com - Investing.com Canada

Mar 02, 2026

Canaccord reiterates Biodesix stock rating on strong Q4 results - Investing.com

Mar 02, 2026

Mar 01, 2026

Biodesix (BDSX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 01, 2026

Monashee Investment Management LLC Cuts Holdings in Biodesix, Inc. $BDSX - MarketBeat

Mar 01, 2026

Feb 28, 2026

Q4 2025 Biodesix Inc Earnings Call Transcript - GuruFocus

Feb 28, 2026

William Blair Upgrades Biodesix (BDSX) - Nasdaq

Feb 28, 2026

Feb 27, 2026

William Blair Upgrades BDSX (Biodesix, Inc.) to Outperform Feb 2026 - Meyka

Feb 27, 2026

Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results, Beats Estimates By $0.56 EPS - MarketBeat

Feb 27, 2026

William Blair Upgrades Biodesix (BDSX) to 'Outperform' | BDSX St - GuruFocus

Feb 27, 2026

Biodesix expects 2026 sales to crack $100M - BizWest

Feb 27, 2026